Control of experimental pulmonary tuberculosis depends more on immunostimulatory leukotrienes than on the absence of immunosuppressive prostaglandins

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 85, Issue 2, 2011, Pages 75-81

  Peres Buzalaf, C ^a   de Paula, L ^a   Frantz, F G ^a   Soares, E M ^a   Medeiros, A I ^a   Peters Golden, M ^b   Silva, C L ^a   Faccioli, L H ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Cytokines; Immunomodulation; Leukotrienes; Mycobacterium tuberculosis; Prostaglandins

Indexed keywords

3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; CELECOXIB; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; LEUKOTRIENE B4; NITRIC OXIDE; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOKINE PRODUCTION; EXPERIMENTAL INFECTION; HOST RESISTANCE; INTERFERON PRODUCTION; LUNG ALVEOLUS MACROPHAGE; LUNG TUBERCULOSIS; MALE; MONONUCLEAR CELL; MOUSE; NEUTROPHIL COUNT; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN BLOOD LEVEL; SURVIVAL; TUBERCULOSIS CONTROL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; IMMUNOSUPPRESSIVE AGENTS; INDOLES; LEUKOTRIENES; LIPOXYGENASE INHIBITORS; LUNG; MALE; MICE; MICE, INBRED BALB C; MYCOBACTERIUM TUBERCULOSIS; NITRIC OXIDE; PROSTAGLANDINS; TUBERCULOSIS, PULMONARY;

ANIMALIA; BACTERIA (MICROORGANISMS); MUS; MYCOBACTERIUM TUBERCULOSIS;

EID: 79959595690     PISSN: 09523278     EISSN: 15322823     Source Type: Journal    
DOI: 10.1016/j.plefa.2011.04.024     Document Type: Article

References (37)

1. WHO, Tuberculosis, 2007, http://www.who.int/tb/en/.
2. Cooper A.M., Flynn J.L. The protective immune response to Mycobacterium tuberculosis. Curr. Opin. Immunol. 1995, 7:512-516.
3. Flynn J.L., Chan J. Immunology of tuberculosis. Annu. Rev. Immunol. 2001, 19:93-129.
4. Flynn J.L., Goldstein M.M., Chan J., et al. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 1995, 2:561-572.
5. Flynn J.L., Goldstein M.M., Triebold K.J., Sypek J., Wolf S., Bloom B.R. IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. J. Immunol. 1995, 155:2515-2524.
6. Goldfeld A.E. Genetic susceptibility to pulmonary tuberculosis in Cambodia. Tuberculosis (Edinburgh) 2004, 84:76-81.
7. Funk C.D. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 2001, 294:1871-1875.
8. Byrum R.S., Goulet J.L., Griffiths R.J., Koller B.H. Role of the 5-lipoxygenase-activating protein (FLAP) in murine acute inflammatory responses. J. Exp. Med. 1997, 185:1065-1075.
9. Charbeneau R.P., Peters-Golden M. Eicosanoids: mediators and therapeutic targets in fibrotic lung disease. Clin. Sci. (London) 2005, 108:479-491.
10. Rangel Moreno J., Estrada Garcia I., De La Luz Garcia M., Hernandez D., Aguilar Leon R., Marquez R., Hernandez Pando The role of prostaglandin E2 in the immunopathogenesis of experimental pulmonary tuberculosis. Immunology 2002, 106:257-266.
11. Aronoff D.M., Canetti C., Peters-Golden M. Prostaglandin E2 inhibits alveolar macrophage phagocytosis through an E-prostanoid 2 receptor-mediated increase in intracellular cyclic AMP. J. Immunol. 2004, 173:559-565.
12. Serezani C.H., Chung J., Ballinger M.N., Moore B.B., Aronoff D.M., Peters-Golden M. Prostaglandin E2 suppresses bacterial killing in alveolar macrophages by inhibiting NADPH oxidase. Am. J. Respir. Cell Mol. Biol. 2007, 37:562-570.
13. Kunkel S.L., Wiggins R.C., Chensue S.W., Larrick J. Regulation of macrophage tumor necrosis factor production by prostaglandin E2. Biochem. Biophys. Res. Commun. 1986, 137:404-410.
14. Snijdewint F.G., Kalinski P., Wierenga E.A., Bos J.D., Kapsenberg M.L. Prostaglandin E2 differentially modulates cytokine secretion profiles of human T helper lymphocytes. J. Immunol. 1993, 150:5321-5329.
15. van der Pouw Kraan T.C., Boeije L.C., Smeenk R.J., Wijdenes J., Aarden L.A. Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production. J. Exp. Med. 1995, 181:775-779.
16. Harizi H., Juzan M., Pitard V., Moreau J.F., Gualde N. Cyclooxygenase-2-issued prostaglandin E2 enhances the production of endogenous IL-10, which down-regulates dendritic cell functions. J. Immunol. 2002, 168:2255-2263.
17. Peres C.M., de Paula L., Medeiros A.I., et al. Inhibition of leukotriene biosynthesis abrogates the host control of Mycobacterium tuberculosis. Microbes Infect. 2007, 9:483-489.
18. Krarup E., Vestbo J., Benfield T.L., Lundgren J.D. Interleukin-8 and leukotriene B4 in bronchoalveolar lavage fluid from HIV-infected patients with bacterial pneumonia. Respir. Med. 1997, 91:317-321.
19. Coffey M.J., Phare S.M., George S., Peters-Golden M., Kazanjian P.H. Granulocyte colony-stimulating factor administration to HIV-infected subjects augments reduced leukotriene synthesis and anticryptococcal activity in neutrophils. J. Clin. Invest. 1998, 102:663-670.
20. Medeiros A.I., Sa-Nunes A., Soares E.G., Peres C.M., Silva C.L., Faccioli L.H. Blockade of endogenous leukotrienes exacerbates pulmonary histoplasmosis. Infect. Immunol. 2004, 72:1637-1644.
21. Serezani C.H., Aronoff D.M., Jancar S., Mancuso P., Peters-Golden M. Leukotrienes enhance the bactericidal activity of alveolar macrophages against Klebsiella pneumoniae through the activation of NADPH oxidase. Blood 2005, 106:1067-1075.
22. McDonough K.A., Kress Y. Cytotoxicity for lung epithelial cells is a virulence-associated phenotype of Mycobacterium tuberculosis. Infect. Immunol. 1995, 63:4802-4811.
23. Hao Y., Xie T., Korotcov A., et al. Salvianolic acid B inhibits growth of head and neck squamous cell carcinoma in vitro and in vivo via cyclooxygenase-2 and apoptotic pathways. Int. J. Cancer 2009, 124:2200-2209.
24. Faccioli L.H., Souza G.E., Cunha F.Q., Poole S., Ferreira S.H. Recombinant interleukin-1 and tumor necrosis factor induce neutrophil migration in vivo by indirect mechanisms. Agents Actions 1990, 30:344-349.
25. Silva C.L., Lowrie D.B. A single mycobacterial protein (hsp 65) expressed by a transgenic antigen-presenting cell vaccinates mice against tuberculosis. Immunology 1994, 82:244-248.
26. Pradelles P., Grassi J., Maclouf J. Enzyme immunoassays of eicosanoids using acetylcholinesterase. Methods Enzymol. 1990, 187:24-34.
27. Stuehr D.J., Nathan C.F. Nitric oxide: a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J. Exp. Med. 1989, 169:1543-1555.
28. Sestini P., Armetti L., Gambaro G., et al. Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma. Am. J. Respir. Crit. Care Med. 1996, 153:572-575.
29. Kuroda E., Yamashita U. Mechanisms of enhanced macrophage-mediated prostaglandin E2 production and its suppressive role in Th1 activation in Th2-dominant BALB/c mice. J. Immunol. 2003, 170:757-764.
30. Araico A., Terencio M.C., Alcaraz M.J., Dominguez J.N., Leon C., Ferrandiz M.L. Evaluation of the anti-inflammatory and analgesic activity of Me-UCH9, a dual cyclooxygenase-2/5-lipoxygenase inhibitor. Life Sci. 2007, 80:2108-2117.
31. Raupach B., Kaufmann S.H. Immune responses to intracellular bacteria. Curr. Opin. Immunol. 2001, 13:417-428.
32. Cooper A.M., Magram J., Ferrante J., Orme I.M. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J. Exp. Med. 1997, 186:39-45.
33. Lowrie D.B., Silva C.L. Enhancement of immunocompetence in tuberculosis by DNA vaccination. Vaccine 2000, 18:1712-1716.
34. Moore K.W., O'Garra A., de Waal Malefyt R., Vieira P., Mosmann T.R. Interleukin-10. Annu. Rev. Immunol. 1993, 11:165-190.
35. Peters-Golden M., Henderson W.R. Leukotrienes. N. Engl. J. Med. 2007, 357:1841-1854.
36. Peres C.M., Aronoff D.M., Serezani C.H., Flamand N., Faccioli L.H., Peters-Golden M. Specific leukotriene receptors couple to distinct G proteins to effect stimulation of alveolar macrophage host defense functions. J. Immunol. 2007, 179:5454-5461.
37. Lee S.P., Serezani C.H., Medeiros A.I., Ballinger M.N., Peters-Golden M. Crosstalk between prostaglandin E2 and leukotriene B4 regulates phagocytosis in alveolar macrophages via combinatorial effects on cyclic AMP. J. Immunol. 2009, 182:530-537.